Compared to healthy controls, JDM patients had significantly elevated levels of IL-6, IL-15, IL-17, IL-18, CXCL9, CXCL10, IFNα and IFNβ (padj =0.001-0.03). This evidence concerns the gene IFNB1 and juvenile dermatomyositis.